Skip to main content
. 2022 Jun 17;16:38–46. doi: 10.1016/j.rpsm.2022.05.008

Table 2.

Clinical trajectory over the 12-month follow-up period.

Onset 12 months p-value
n (%) n (%)
Overall symptoms, number <0.001
 0 66 (13.8) 253 (52.8)
 1 66 (13.8) 92 (19.2)
 2 97 (20.2) 59 (12.3)
 3 74 (15.4) 34 (7.1)
 4 76 (15.9) 12 (2.5)
 ≥5 100 (20.9) 29 (6.1)



Mental health domain-related symptoms 205 (42.8) 141 (29.4) <0.001
 Symptoms of psychiatric disorders (depression, anxiety, insomnia) 4 (0.8) 49 (10.2) <0.001
 Lack of concentration and focus 14 (2.9) 96 (20.0) <0.001
 Fatigue 201 (42.0) 50 (10.4) <0.001



Feeling of needing psychological support (n/N) 57/398 (14.3)
Feeling of being recovered (n/N) 351/466 (75.3)



Neurological domain-related symptoms 192 (40.1) 36 (7.5) <0.001
 Headache 168 (35.1) 24 (5.0) <0.001
 Neurological symptoms 31 (6.5) 13 (2.7) 0.004



Anosmia/dysgeusia 268 (55.9) 53 (11.1) <0.001
Rheumatological symptoms 66 (13.8) 61 (12.7) 0.578



Respiratory domain-related symptoms 296 (61.8) 67 (14.0) <0.001
 Dyspnoea 156 (32.6) 44 (9.2) <0.001
 URTI symptoms 51 (10.6) 6 (1.2) <0.001
 Cough 213 (44.5) 13 (2.7) <0.001
 Chest pain 19 (4.0) 13 (2.7) 0.273



Cutaneous symptoms 7 (1.5) 6 (1.2) 0.781
Gastrointestinal symptoms 173 (36.1) 17 (3.5) <0.001

URTI, upper respiratory tract infection.